Transcode Therapeutics, Inc. (RNAZ) insider trading
Over the last 12 months, 0 insiders bought $0 and 0 insiders sold $0 of Transcode Therapeutics, Inc. stock on the open market, according to SEC Form 4 filings.
Over the last 12 months, 0 insiders bought $0 and 0 insiders sold $0 of Transcode Therapeutics, Inc. stock on the open market, according to SEC Form 4 filings.